Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Forsgren

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Molecular Biosystems|February 18, 2016
Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjectsAnna Wuolikainen, Pär Jonsson, Maria Ahnlund, et al.
Brain Communications|March 30, 2022
Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based studyDavid Bäckström, Gabriel Granåsen, Susanna Jakobson Mo, et al.
Neuroscience Letters|August 24, 2017
The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signalVictoria Berge-Seidl, Lasse Pihlstrøm, Jodi Maple-Grødem, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 2, 2018
Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease: a randomised blinded evaluationPatric Blomstedt, Rasmus Stenmark Persson, Gun-Marie Hariz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 19, 2012
No GGGGCC-hexanucleotide repeat expansion in C9ORF72 in parkinsonism patients in SwedenChizuru Akimoto, Lars Forsgren, Jan Linder, et al.
Neurology|November 2, 2018
Early predictors of mortality in parkinsonism and Parkinson disease: A population-based studyDavid Bäckström, Gabriel Granåsen, Magdalena Eriksson Domellöf, et al.
JAMA Neurology|August 11, 2015
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson DiseaseDavid C Bäckström, Magdalena Eriksson Domellöf, Jan Linder, et al.
Journal of Parkinson'S Disease|August 14, 2013
Plasma-based circulating MicroRNA biomarkers for Parkinson's diseaseSok Kean Khoo, David Petillo, Un Jung Kang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2019
α-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patientsWojciech Paslawski, Justyna Zareba-Paslawska, Xiaoqun Zhang, et al.
Plos One|March 13, 2014
A generic method for design of oligomer-specific antibodiesKristoffer Brännström, Malin Lindhagen-Persson, Anna L Gharibyan, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Molecular Biosystems|February 18, 2016
Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjectsAnna Wuolikainen, Pär Jonsson, Maria Ahnlund, et al.
Brain Communications|March 30, 2022
Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based studyDavid Bäckström, Gabriel Granåsen, Susanna Jakobson Mo, et al.
Neuroscience Letters|August 24, 2017
The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signalVictoria Berge-Seidl, Lasse Pihlstrøm, Jodi Maple-Grødem, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 2, 2018
Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease: a randomised blinded evaluationPatric Blomstedt, Rasmus Stenmark Persson, Gun-Marie Hariz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 19, 2012
No GGGGCC-hexanucleotide repeat expansion in C9ORF72 in parkinsonism patients in SwedenChizuru Akimoto, Lars Forsgren, Jan Linder, et al.
Neurology|November 2, 2018
Early predictors of mortality in parkinsonism and Parkinson disease: A population-based studyDavid Bäckström, Gabriel Granåsen, Magdalena Eriksson Domellöf, et al.
JAMA Neurology|August 11, 2015
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson DiseaseDavid C Bäckström, Magdalena Eriksson Domellöf, Jan Linder, et al.
Journal of Parkinson'S Disease|August 14, 2013
Plasma-based circulating MicroRNA biomarkers for Parkinson's diseaseSok Kean Khoo, David Petillo, Un Jung Kang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2019
α-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patientsWojciech Paslawski, Justyna Zareba-Paslawska, Xiaoqun Zhang, et al.
Plos One|March 13, 2014
A generic method for design of oligomer-specific antibodiesKristoffer Brännström, Malin Lindhagen-Persson, Anna L Gharibyan, et al.
Pageof 11